Survival Analysis of Pathological T3a Upstaging in Clinical T1 Renal Cell Carcinoma

Aim: To evaluate the oncological outcomes of pathological T3a upstaging from clinical T1 renal cell carcinoma. Patients and Methods: We retrospectively studied patients who underwent radical or partial nephrectomy for clinical T1 renal tumors. Results: The median follow-up period was 44 months. At t...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:In Vivo
Autors principals: LAI, GU-SHUN, LI, JIAN-RI, WANG, SHIAN-SHIANG, CHEN, CHUAN-SHU, YANG, CHUN-KUANG, HUNG, SHENG-CHUN, CHENG, CHEN-LI, OU, YEN-CHUAN, CHIU, KUN-YUAN
Format: Artigo
Idioma:Inglês
Publicat: International Institute of Anticancer Research 2020
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7157890/
https://ncbi.nlm.nih.gov/pubmed/32111787
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.11841
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars